23,24 If Medicare cannot consider multiple versions of a drug together, newer versions may not be eligible for negotiation until years after the original product becomes eligible. For example, we simulated that adalimumab would have been eligible for a negotiated price in 2018. In that same year...
90 This strategy was similar to China’s national volume-based procurement (NVBP) for generic pharmaceuticals, which has also yielded favorable outcomes.91 Therefore, accelerating the uptake of cancer biosimilars through NVBP and multistakeholder consensus should be considered in China. Additionally, the...
Quarterly number of prescriptions and reimbursement data were calculated for the trends analysis. Study drugs included all brand and generic names of anti-TNF biologics (e.g., abatacept, adalimumab, anakinra, certolizumab, etanercept, golimumab, infliximab, and rituximab). Market shares for biologics ...
The company recently announced an affordability program with Boehringer Ingelheim to provide its Humira® biosimilar (adalimumab) at a low cash price available exclusively on GoodRx. Similarly, the company has partnered with Sanofi to offer its insulin Lantus at just $35. Consumers can acce...